Works by Chavez, Julio C.

Results: 77
    1

    Interdisciplinary Management of Chemorefractory NHL Patients Treated with KTE-C19 (Anti-CD19 CAR T Cells) in Phase 1 of the ZUMA-1 Clinical Study.

    Published in:
    Journal of Oncology Navigation & Survivorship, 2016, v. 7, n. 9, p. 56
    By:
    • Beaupierre, Alix;
    • Patterson, Amy;
    • Kahle, Nicole;
    • Locke, Frederick L.;
    • Neelapu, Sattva S.;
    • Bartlett, Nancy L.;
    • Siddiqi, Tanya;
    • Chavez, Julio C.;
    • Hosing, Chitra M.;
    • Cashen, Amanda;
    • Budde, Lihua E.;
    • Navale, Lynn;
    • Yizhou Jiang;
    • Elias, Meg;
    • Aycock, Jeff;
    • Wiezorek, Jeff;
    • Go, William Y.
    Publication type:
    Article
    2
    3

    Canal catiónico específico del espermatozoide: CatSper.

    Published in:
    TIP Revista Especializada en Ciencias Químico-Biológicas, 2024, v. 27, p. 1, doi. 10.22201/fesz.23958723e.2024.685
    By:
    • Mendoza-Sánchez, José Edwin;
    • Chávez-Zamora, Julio C.;
    • Rodríguez-Tobón, Ahiezer;
    • Morales Otal, Adriana;
    • Arenas-Ríos, Edith
    Publication type:
    Article
    4
    5

    Frontline treatment approaches in TP53-aberrant mantle cell lymphoma.

    Published in:
    Leukemia & Lymphoma, 2023, v. 64, n. 1, p. 230, doi. 10.1080/10428194.2022.2131407
    By:
    • Shah, Nikesh N.;
    • Castillo-Tokumori, Franco;
    • Whiting, Junmin;
    • Boulware, David;
    • Sandoval-Sus, Jose;
    • Knepper, Todd C.;
    • Hussaini, Mohammad;
    • Tao, Jianguo;
    • Chavez, Julio C.;
    • Isenalumhe, Leidy;
    • Gaballa, Sameh;
    • Saeed, Hayder;
    • Bello, Celeste;
    • Sokol, Lubomir;
    • Pinilla-Ibarz, Javier;
    • Shah, Bijal D.
    Publication type:
    Article
    6

    Efficacy of salvage chemotherapy in diffuse large B cell lymphoma with primary treatment failure according to putative cell of origin.

    Published in:
    Leukemia & Lymphoma, 2019, v. 60, n. 4, p. 940, doi. 10.1080/10428194.2018.1515944
    By:
    • Badar, Talha;
    • Hamadani, Mehdi;
    • Bachanova, Veronika;
    • Maddocks, Kami J.;
    • Umyarova, Elvira;
    • Chavez, Julio C.;
    • Epperla, Narendranath;
    • Chhabra, Saurabh;
    • Xavier, Ana C.;
    • Karmali, Reem;
    • Salhab, Mohammed;
    • Reddy, Nishitha;
    • Glenn, Martha J.;
    • Hernandez-Ilizaliturri, Francisco J.;
    • Flowers, Christopher R.;
    • Evens, Andrew M;
    • Zhou, Zheng;
    • Lansigan, Frederick;
    • Barta, Stefan K.;
    • Cohen, Jonathon B
    Publication type:
    Article
    7
    8
    9
    10
    11
    12
    13

    Outcomes of patients with limited‐stage plasmablastic lymphoma: A multi‐institutional retrospective study.

    Published in:
    American Journal of Hematology, 2023, v. 98, n. 2, p. 300, doi. 10.1002/ajh.26784
    By:
    • Hess, Brian T.;
    • Giri, Anshu;
    • Park, Yeonhee;
    • Patel, Krina K.;
    • Link, Brian K.;
    • Nowakowski, Grzegorz S.;
    • Maliske, Seth M.;
    • Fortin, Sonia;
    • Chavez, Julio C.;
    • Saeed, Hayder;
    • Hill, Brian T.;
    • Mejia Garcia, Alex V.;
    • Maddocks, Kami J.;
    • Hanel, Walter;
    • Wagner‐Johnston, Nina D.;
    • Messmer, Marcus R.;
    • Kahl, Brad S.;
    • Watkins, Marcus;
    • Alderuccio, Juan Pablo;
    • Lossos, Izidore S.
    Publication type:
    Article
    14
    15
    16
    17

    Diffuse large B-cell lymphoma with primary treatment failure: Ultra-high risk features and benchmarking for experimental therapies.

    Published in:
    American Journal of Hematology, 2017, v. 92, n. 2, p. 161, doi. 10.1002/ajh.24615
    By:
    • Costa, Luciano J.;
    • Maddocks, Kami;
    • Epperla, Narendranath;
    • Reddy, Nishitha M.;
    • Karmali, Reem;
    • Umyarova, Elvira;
    • Bachanova, Veronika;
    • Costa, Cristiana;
    • Glenn, Martha J.;
    • Chavez, Julio C.;
    • Calzada, Oscar;
    • Lansigan, Frederick;
    • Nasheed, Hossain;
    • Barta, Stefan K.;
    • Zhou, Zheng;
    • Jaglal, Michael;
    • Chhabra, Saurabh;
    • Hernandez-Ilizaliturri, Francisco;
    • Xavier, Ana C.;
    • Mehta, Amitkumar
    Publication type:
    Article
    18
    19

    Outcomes of patients with Richter transformation who received no prior chemoimmunotherapy for their CLL.

    Published in:
    Blood Cancer Journal, 2025, v. 15, n. 1, p. 1, doi. 10.1038/s41408-025-01236-6
    By:
    • Kittai, Adam S.;
    • Huang, Ying;
    • Miller, Sarah;
    • Allan, John N.;
    • Bhat, Seema A.;
    • Bond, David A.;
    • Brander, Danielle M.;
    • Byrd, John C.;
    • Chavez, Julio C.;
    • Chong, Elise;
    • Davids, Matthew S.;
    • Danilov, Alexey V.;
    • Ding, Wei;
    • Dowling, Mark R.;
    • Dvorak-Kornaus, Kaitlyn;
    • Freedman, Hannah;
    • Hampel, Paul J.;
    • Ho, Carrie;
    • Hwang, Steven R.;
    • Islam, Prioty
    Publication type:
    Article
    20
    21

    Long-term follow up of the combination of ofatumumab, high-dose methylprednisolone, and lenalidomide for untreated chronic lymphocytic leukemia with biomarker analysis.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 382, doi. 10.1016/j.clml.2024.02.001
    By:
    • Chavez, Julio C;
    • Grajales, Ariel;
    • Sandoval-Sus, Jose;
    • Turba, Elyce;
    • Nodzon, Lisa;
    • Uriepero-Palma, Angimar;
    • Ammad-Ud-Din, Mohammad;
    • Sahakian, Eva;
    • Komrokji, Rami;
    • Sokol, Lubomir;
    • Locke, Frederick L;
    • Shah, Bijal;
    • Lancet, Jeffrey;
    • Sotomayor, Eduardo M;
    • Kharfan-Dabaja, Mohamed A.;
    • Bello, Celeste;
    • Pinilla-Ibarz, Javier
    Publication type:
    Article
    22
    23

    Severity of Cytokine Release Syndrome Influences Outcome After Axicabtagene Ciloleucel for Large B cell Lymphoma: Results from the US Lymphoma CAR-T Consortium.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2022, v. 22, n. 10, p. 753, doi. 10.1016/j.clml.2022.05.004
    By:
    • Jacobs, Miriam T.;
    • Jain, Michael D.;
    • Gao, Feng;
    • Nastoupil, Loretta J.;
    • Spiegel, Jay Y.;
    • Lin, Yi;
    • Dahiya, Saurabh;
    • Lunning, Matthew;
    • Lekakis, Lazaros;
    • Reagan, Patrick M.;
    • Oluwole, Olalekan O.;
    • McGuirk, Joseph;
    • Deol, Abhinav;
    • Sehgal, Alison;
    • Goy, Andre;
    • Hill, Brian T.;
    • Andreadis, Charalambos;
    • Munoz, Javier;
    • Chavez, Julio C.;
    • Bennani, N. Nora
    Publication type:
    Article
    24

    IBCL-203: Umbralisib, a PI3Kδ/CK1ε Dual Inhibitor Demonstrates Marked Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma (iNHL): Results from the Phase 2 Global UNITY-NHL Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S404, doi. 10.1016/S2152-2650(21)01912-1
    By:
    • Ghosh, Nilanjan;
    • Zinzani, Pier Luigi;
    • Samaniego, Felipe;
    • Jurczak, Wojciech;
    • Derenzini, Enrico;
    • Reeves, James A.;
    • Knopinska-Posluszny, Wanda;
    • Cheah, Chan Y.;
    • Phillips, Tycel;
    • Lech-Maranda, Ewa;
    • Cheson, Bruce;
    • Calmi, Paolo;
    • Grosicki, Sebastian;
    • Leslie, Lori A.;
    • Chavez, Julio C.;
    • Fonseca, Gustavo;
    • Babu, Sunil;
    • Hodson, Daniel J.;
    • Shao, Spencer H.;
    • Burke, John M.
    Publication type:
    Article
    25

    IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S403, doi. 10.1016/S2152-2650(21)01911-X
    By:
    • Schuster, Stephen J.;
    • Dickinson, Michael;
    • Dreyling, Martin;
    • Martinez-Lopez, Joaquin;
    • Kolstad, Arne;
    • Butler, Jason;
    • Ghosh, Monalisa;
    • Popplewell, Leslie;
    • Chavez, Julio C.;
    • Bachy, Emmanuel;
    • Koji Kato;
    • Harigae, Hideo;
    • Kersten, Marie José;
    • Andreadis, Charalambos;
    • Riedell, Peter;
    • Zia, Aiesha;
    • Morisse, Mony Chenda;
    • Fowler, Nathan Hale;
    • Thieblemont, Catherine
    Publication type:
    Article
    26

    Poster: IBCL-195: Primary Analysis of the Phase 2 ELARA Trial: Tisagenlecleucel Efficacy and Safety in Adult Patients with Relapsed/Refractory Follicular Lymphoma (r/r FL).

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S245, doi. 10.1016/S2152-2650(21)01539-1
    By:
    • Schuster, Stephen J.;
    • Dickinson, Michael;
    • Dreyling, Martin;
    • Martinez-Lopez, Joaquin;
    • Kolstad, Arne;
    • Butler, Jason;
    • Ghosh, Monalisa;
    • Popplewell, Leslie;
    • Chavez, Julio C.;
    • Bachy, Emmanuel;
    • Kato, Koji;
    • Harigae, Hideo;
    • Kersten, Marie José;
    • Andreadis, Charalambos;
    • Riedell, Peter;
    • Zia, Aiesha;
    • Morisse, Mony Chenda;
    • Fowler, Nathan Hale;
    • Thieblemont, Catherine
    Publication type:
    Article
    27

    Poster: IBCL-203: Umbralisib, a PI3Kδ/CK1ε Dual Inhibitor Demonstrates Marked Clinical Activity in Patients with Relapsed or Refractory Indolent Non-Hodgkin Lymphoma (iNHL): Results from the Phase 2 Global UNITY-NHL Trial.

    Published in:
    Clinical Lymphoma, Myeloma & Leukemia, 2021, v. 21, p. S244, doi. 10.1016/S2152-2650(21)01537-8
    By:
    • Ghosh, Nilanjan;
    • Zinzani, Pier Luigi;
    • Samaniego, Felipe;
    • Jurczak, Wojciech;
    • Derenzini, Enrico;
    • Reeves, James A.;
    • Knopinska-Posluszny, Wanda;
    • Cheah, Chan Y.;
    • Phillips, Tycel;
    • Lech-Maranda, Ewa;
    • Cheson, Bruce;
    • Caimi, Paolo;
    • Grosicki, Sebastian;
    • Leslie, Lori A.;
    • Chavez, Julio C.;
    • Fonseca, Gustavo;
    • Babu, Sunil;
    • Hodson, Daniel J.;
    • Shao, Spencer H.;
    • Burke, John M.
    Publication type:
    Article
    28
    29
    30
    31
    32
    33
    34
    35
    36

    A cytoplasmic Slo3 isoform is expressed in somatic tissues.

    Published in:
    Molecular Biology Reports, 2019, v. 46, n. 5, p. 5561, doi. 10.1007/s11033-019-04943-z
    By:
    • Chávez, Julio C.;
    • Vicens, Alberto;
    • Wrighton, David C.;
    • Andrade-López, Karla;
    • Beltrán, Carmen;
    • Gutiérrez, Rosa M.;
    • Lippiat, Jonathan D.;
    • Treviño, Claudia L.
    Publication type:
    Article
    37
    38
    39
    40

    Long-term survival in AIDS-related primary central nervous system lymphoma.

    Published in:
    Neuro-Oncology, 2017, v. 19, n. 1, p. 99, doi. 10.1093/neuonc/now155
    By:
    • Gupta, Neel K.;
    • Nolan, Amber;
    • Omuro, Antonio;
    • Reid, Erin G.;
    • Chia-Ching Wang;
    • Mannis, Gabriel;
    • Jaglal, Michael;
    • Chavez, Julio C.;
    • Rubinstein, Paul G.;
    • Griffin, Ann;
    • Abrams, Donald I.;
    • Hwang, Jimmy;
    • Kaplan, Lawrence D.;
    • Luce, Judith A.;
    • Volberding, Paul;
    • Treseler, Patrick A.;
    • Rubenstein, James L.
    Publication type:
    Article
    41

    C-MYC-positive relapsed and refractory, diffuse large B-cell lymphoma: Impact of additional "hits" and outcomes with subsequent therapy.

    Published in:
    2017
    By:
    • Epperla, Narendranath;
    • Maddocks, Kami J.;
    • Salhab, Mohammed;
    • Chavez, Julio C.;
    • Reddy, Nishitha;
    • Karmali, Reem;
    • Umyarova, Elvira;
    • Bachanova, Veronika;
    • Costa, Cristiana;
    • Glenn, Martha;
    • Calzada, Oscar;
    • Xavier, Ana C.;
    • Zhou, Zheng;
    • Hossain, Nasheed M.;
    • Hernandez‐Ilizaliturri, Francisco J.;
    • Al‐Mansour, Zeina;
    • Barta, Stefan K.;
    • Chhabra, Saurabh;
    • Lansigan, Frederick;
    • Mehta, Amitkumar
    Publication type:
    journal article
    42
    43

    Melanoma and CLL co-occurrence and survival: role of KC history.

    Published in:
    BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11573-z
    By:
    • Zhao, Yayi;
    • Amorrortu, Rossybelle P.;
    • Stewart, Sandra C.;
    • Ghia, Kavita M.;
    • Williams, Vonetta L.;
    • Sondak, Vernon K.;
    • Tsai, Kenneth Y.;
    • Pinilla-Ibarz, Javier;
    • Chavez, Julio C.;
    • Rollison, Dana E.
    Publication type:
    Article
    44

    Acute patient‐reported outcomes in B‐cell malignancies treated with axicabtagene ciloleucel.

    Published in:
    Cancer Medicine, 2021, v. 10, n. 6, p. 1936, doi. 10.1002/cam4.3664
    By:
    • Hoogland, Aasha I.;
    • Jayani, Reena V.;
    • Collier, Aaron;
    • Irizarry‐Arroyo, Nathaly;
    • Rodriguez, Yvelise;
    • Jain, Michael D.;
    • Booth‐Jones, Margaret;
    • Hyland, Kelly A.;
    • James, Brian W.;
    • Barata, Anna;
    • Bachmeier, Christina A.;
    • Chavez, Julio C.;
    • Khimani, Farhad;
    • Krivenko, Gabriel S.;
    • Lazaryan, Aleksandr;
    • Liu, Hien D.;
    • Nishihori, Taiga;
    • Pinilla‐Ibarz, Javier;
    • Shah, Bijal D.;
    • Abidi, Muneer
    Publication type:
    Article
    45
    46
    47
    48
    49

    Poor outcomes for double‐hit lymphoma patients treated with curative‐intent second‐line immunochemotherapy following failure of intensive front‐line immunochemotherapy.

    Published in:
    British Journal of Haematology, 2020, v. 189, n. 2, p. 313, doi. 10.1111/bjh.16319
    By:
    • Landsburg, Daniel J.;
    • Ayers, Emily C.;
    • Bond, David A.;
    • Maddocks, Kami J.;
    • Karmali, Reem;
    • Behdad, Amir;
    • Curry, Madeira;
    • Wagner‐Johnston, Nina D.;
    • Modi, Dipenkumar;
    • Ramchandren, Radhakrishnan;
    • Assouline, Sarit E.;
    • Faramand, Rawan;
    • Chavez, Julio C.;
    • Torka, Pallawi;
    • Mier Hicks, Angel;
    • Medeiros, L. Jeffrey;
    • Li, Shaoying
    Publication type:
    Article
    50